Form 4: LeMaitre Vascular CEO George W. LeMaitre Sells Shares Under 10b5-1 Plan

George W. LeMaitre, Chairman and CEO of LeMaitre Vascular, sold 57,372 shares of common stock at a weighted average price of $86.6937 per share on July 16, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On July 16, 2024, George W. LeMaitre, the Chairman and CEO of LeMaitre Vascular, sold 57,372 shares of the company's common stock.
• The sale was executed at a weighted average price of $86.6937 per share.
• The transactions occurred within a price range of $86.45 to $86.98.
• The sale was conducted under a pre-arranged 10b5-1 trading plan adopted on June 2, 2023.
• Following the transaction, LeMaitre directly owns 1,900,956 shares of LeMaitre Vascular.
• Nathaniel R.J. Ulrich signed the form on behalf of George W. LeMaitre on July 18, 2024.

Sentiment

Score: 5

Explanation: The document reports a routine stock sale by the CEO under a pre-arranged plan. It doesn't inherently indicate positive or negative sentiment, but rather a planned transaction.

Industry Context

Sales by insiders are a common occurrence and are often pre-planned through 10b5-1 trading plans to avoid accusations of trading on material non-public information. The market typically analyzes the size and frequency of such sales to gauge insider sentiment.

Stakeholder Impact

• The stock sale could have a minor impact on shareholder sentiment, depending on how the market interprets the transaction.

Key Dates